You are using an older browser version. Please use a supported version for the best MSN experience.

FDA panel approves Pfizer Covid booster for 65 and up, high risk

An FDA panel has voted to recommend approval of a Pfizer Covid-19 booster shot for people 65 years and older as well as those at high risk.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon